DC
NVO

Diametric Capital’s Novo Nordisk NVO Stock Holding History

Diametric Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,359
Closed -$765K – 457
2024
Q2 		$765K Buy
5,359
+2,158
+67% +$286K 0.42% 64
2024
Q1 		$411K Buy
+3,201
New +$381K 0.23% 105
2019
Q4 		– Sell
-35,462
Closed -$917K – 147
2019
Q3 		$917K Buy
+35,462
New +$897K 0.76% 47
2019
Q2 		– Sell
-53,910
Closed -$1.41M – 144
2019
Q1 		$1.41M Buy
+53,910
New +$1.32M 1.11% 33

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Diametric Capital's NVO Position: Q3 2024 in Review

Diametric Capital sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 5,359 shares — an estimated $765K sold.

Diametric Capital first reported a position in NVO in Q1 2019 and held it in 4 quarters. The position peaked at $1.41M in Q1 2019. 1,784 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Diametric Capital reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • Diametric Capital sold 5,359 Novo Nordisk shares in Q3 2024, an estimated $765K.
  • Diametric Capital first reported a position in Novo Nordisk in Q1 2019 and held it in 4 quarters.
  • Diametric Capital's Novo Nordisk position peaked at $1.41M in Q1 2019.
  • 1,784 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Diametric Capital's 13F filing for Q3 2024, filed 13 Nov 2024.